Jin Medical International Ltd. (NASDAQ: ZJYL) Stock Competitors & Peer Comparison
See ZJYL's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ZJYL and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ZJYL | $4.91 | +16.63% | 38.4M | 33.58 | $0.15 | N/A |
| ISRG | $449.53 | -0.11% | 155.8B | 46.73 | $9.62 | N/A |
| BDX | $214.52 | +0.90% | 58.4B | 16.50 | $13.00 | +1.86% |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +1.86% |
| MDLN | $42.16 | +3.06% | 37B | 30.89 | $1.36 | N/A |
| RMD | $238.53 | +2.18% | 33.6B | 20.69 | $11.53 | +1.06% |
| WST | $412.86 | +0.08% | 28.8B | 44.88 | $9.20 | +0.22% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| SOLV | $88.62 | -1.62% | 15.1B | 12.48 | $7.10 | N/A |
| BDXB | $48.16 | +1.39% | 13.7B | 7.60 | $6.33 | +1.86% |
Stock Comparison
Intuitive Surgical, Inc. (NASDAQ: ISRG)
ZJYL vs ISRG Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, ISRG has a market cap of 155.8B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while ISRG trades at $449.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas ISRG's P/E ratio is 46.73. In terms of profitability, ZJYL's ROE is +0.04%, compared to ISRG's ROE of +0.17%. Regarding short-term risk, ZJYL is more volatile compared to ISRG. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check ISRG's competition here
Becton, Dickinson and Company (NYSE: BDX)
ZJYL vs BDX Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, BDX has a market cap of 58.4B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while BDX trades at $214.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas BDX's P/E ratio is 16.50. In terms of profitability, ZJYL's ROE is +0.04%, compared to BDX's ROE of +0.04%. Regarding short-term risk, ZJYL is more volatile compared to BDX. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check BDX's competition here
Becton, Dickinson and Company (NYSE: BDXA)
ZJYL vs BDXA Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas BDXA's P/E ratio is 45.70. In terms of profitability, ZJYL's ROE is +0.04%, compared to BDXA's ROE of +0.04%. Regarding short-term risk, ZJYL is more volatile compared to BDXA. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check BDXA's competition here
Medline Inc. (NASDAQ: MDLN)
ZJYL vs MDLN Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, MDLN has a market cap of 37B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while MDLN trades at $42.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas MDLN's P/E ratio is 30.89. In terms of profitability, ZJYL's ROE is +0.04%, compared to MDLN's ROE of +0.05%. Regarding short-term risk, ZJYL is more volatile compared to MDLN. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check MDLN's competition here
ResMed Inc. (NYSE: RMD)
ZJYL vs RMD Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, RMD has a market cap of 33.6B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while RMD trades at $238.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas RMD's P/E ratio is 20.69. In terms of profitability, ZJYL's ROE is +0.04%, compared to RMD's ROE of +0.25%. Regarding short-term risk, ZJYL is more volatile compared to RMD. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check RMD's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
ZJYL vs WST Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, WST has a market cap of 28.8B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while WST trades at $412.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas WST's P/E ratio is 44.88. In terms of profitability, ZJYL's ROE is +0.04%, compared to WST's ROE of +0.21%. Regarding short-term risk, ZJYL is more volatile compared to WST. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check WST's competition here
Hologic, Inc. (NASDAQ: HOLX)
ZJYL vs HOLX Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas HOLX's P/E ratio is 31.54. In terms of profitability, ZJYL's ROE is +0.04%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, ZJYL is more volatile compared to HOLX. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check HOLX's competition here
Solventum Corporation (NYSE: SOLV)
ZJYL vs SOLV Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, SOLV has a market cap of 15.1B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while SOLV trades at $88.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas SOLV's P/E ratio is 12.48. In terms of profitability, ZJYL's ROE is +0.04%, compared to SOLV's ROE of +0.03%. Regarding short-term risk, ZJYL is more volatile compared to SOLV. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check SOLV's competition here
Becton, Dickinson and Company (NYSE: BDXB)
ZJYL vs BDXB Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas BDXB's P/E ratio is 7.60. In terms of profitability, ZJYL's ROE is +0.04%, compared to BDXB's ROE of +0.04%. Regarding short-term risk, ZJYL is more volatile compared to BDXB. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check BDXB's competition here
Baxter International Inc. (NYSE: BAX)
ZJYL vs BAX Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, BAX has a market cap of 13.6B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while BAX trades at $26.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas BAX's P/E ratio is 12.66. In terms of profitability, ZJYL's ROE is +0.04%, compared to BAX's ROE of -0.12%. Regarding short-term risk, ZJYL is more volatile compared to BAX. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check BAX's competition here
The Cooper Companies, Inc. (NASDAQ: COO)
ZJYL vs COO Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, COO has a market cap of 12B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while COO trades at $62.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas COO's P/E ratio is 13.80. In terms of profitability, ZJYL's ROE is +0.04%, compared to COO's ROE of +0.07%. Regarding short-term risk, ZJYL is more volatile compared to COO. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check COO's competition here
Repligen Corporation (NASDAQ: RGEN)
ZJYL vs RGEN Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, RGEN has a market cap of 11B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while RGEN trades at $172.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas RGEN's P/E ratio is 95.86. In terms of profitability, ZJYL's ROE is +0.04%, compared to RGEN's ROE of -0.01%. Regarding short-term risk, ZJYL is more volatile compared to RGEN. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check RGEN's competition here
Avantor, Inc. (NYSE: AVTR)
ZJYL vs AVTR Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, AVTR has a market cap of 10.7B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while AVTR trades at $15.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas AVTR's P/E ratio is 18.50. In terms of profitability, ZJYL's ROE is +0.04%, compared to AVTR's ROE of +0.06%. Regarding short-term risk, ZJYL is more volatile compared to AVTR. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check AVTR's competition here
AptarGroup, Inc. (NYSE: ATR)
ZJYL vs ATR Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, ATR has a market cap of 9.1B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while ATR trades at $143.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas ATR's P/E ratio is 25.01. In terms of profitability, ZJYL's ROE is +0.04%, compared to ATR's ROE of +0.10%. Regarding short-term risk, ZJYL is more volatile compared to ATR. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check ATR's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
ZJYL vs BLCO Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, BLCO has a market cap of 7.6B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while BLCO trades at $21.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas BLCO's P/E ratio is 32.78. In terms of profitability, ZJYL's ROE is +0.04%, compared to BLCO's ROE of -0.02%. Regarding short-term risk, ZJYL is more volatile compared to BLCO. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check BLCO's competition here
Teleflex Incorporated (NYSE: TFX)
ZJYL vs TFX Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, TFX has a market cap of 6.2B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while TFX trades at $156.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas TFX's P/E ratio is 17.87. In terms of profitability, ZJYL's ROE is +0.04%, compared to TFX's ROE of +0.10%. Regarding short-term risk, ZJYL is more volatile compared to TFX. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check TFX's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
ZJYL vs MMSI Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, MMSI has a market cap of 5.3B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while MMSI trades at $88.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas MMSI's P/E ratio is 22.52. In terms of profitability, ZJYL's ROE is +0.04%, compared to MMSI's ROE of +0.10%. Regarding short-term risk, ZJYL is more volatile compared to MMSI. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check MMSI's competition here
ICU Medical, Inc. (NASDAQ: ICUI)
ZJYL vs ICUI Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, ICUI has a market cap of 4.5B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while ICUI trades at $178.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas ICUI's P/E ratio is 22.25. In terms of profitability, ZJYL's ROE is +0.04%, compared to ICUI's ROE of +0.03%. Regarding short-term risk, ZJYL is more volatile compared to ICUI. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check ICUI's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
ZJYL vs PLSE Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, PLSE has a market cap of 4.2B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while PLSE trades at $56.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas PLSE's P/E ratio is -48.29. In terms of profitability, ZJYL's ROE is +0.04%, compared to PLSE's ROE of -0.78%. Regarding short-term risk, ZJYL is more volatile compared to PLSE. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check PLSE's competition here
Envista Holdings Corp (NYSE: NVST)
ZJYL vs NVST Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, NVST has a market cap of 4.1B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while NVST trades at $25.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas NVST's P/E ratio is 17.21. In terms of profitability, ZJYL's ROE is +0.04%, compared to NVST's ROE of +0.21%. Regarding short-term risk, ZJYL is more volatile compared to NVST. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check NVST's competition here
Stevanato Group S.p.A. (NYSE: STVN)
ZJYL vs STVN Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, STVN has a market cap of 3.8B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while STVN trades at $13.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas STVN's P/E ratio is 20.95. In terms of profitability, ZJYL's ROE is +0.04%, compared to STVN's ROE of +0.09%. Regarding short-term risk, ZJYL is more volatile compared to STVN. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check STVN's competition here
AtriCure, Inc. (NASDAQ: ATRC)
ZJYL vs ATRC Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, ATRC has a market cap of 2.9B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while ATRC trades at $57.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas ATRC's P/E ratio is 1786.65. In terms of profitability, ZJYL's ROE is +0.04%, compared to ATRC's ROE of +0.03%. Regarding short-term risk, ZJYL is more volatile compared to ATRC. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check ATRC's competition here
Azenta, Inc. (NASDAQ: AZTA)
ZJYL vs AZTA Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, AZTA has a market cap of 2.1B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while AZTA trades at $48.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas AZTA's P/E ratio is 116.43. In terms of profitability, ZJYL's ROE is +0.04%, compared to AZTA's ROE of -0.11%. Regarding short-term risk, ZJYL is more volatile compared to AZTA. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check AZTA's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
ZJYL vs XRAY Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, XRAY has a market cap of 1.9B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while XRAY trades at $9.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas XRAY's P/E ratio is 6.83. In terms of profitability, ZJYL's ROE is +0.04%, compared to XRAY's ROE of -0.09%. Regarding short-term risk, ZJYL is more volatile compared to XRAY. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check XRAY's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
ZJYL vs BLFS Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, BLFS has a market cap of 1.9B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while BLFS trades at $38.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas BLFS's P/E ratio is 37.49. In terms of profitability, ZJYL's ROE is +0.04%, compared to BLFS's ROE of +0.13%. Regarding short-term risk, ZJYL is more volatile compared to BLFS. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check BLFS's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
ZJYL vs KMTS Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, KMTS has a market cap of 1.9B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while KMTS trades at $31.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas KMTS's P/E ratio is -11.94. In terms of profitability, ZJYL's ROE is +0.04%, compared to KMTS's ROE of -0.64%. Regarding short-term risk, ZJYL is more volatile compared to KMTS. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check KMTS's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
ZJYL vs LMAT Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, LMAT has a market cap of 1.8B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while LMAT trades at $79.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas LMAT's P/E ratio is 29.15. In terms of profitability, ZJYL's ROE is +0.04%, compared to LMAT's ROE of +0.15%. Regarding short-term risk, ZJYL is more volatile compared to LMAT. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check LMAT's competition here
STAAR Surgical Company (NASDAQ: STAA)
ZJYL vs STAA Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, STAA has a market cap of 1.3B. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while STAA trades at $26.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas STAA's P/E ratio is 46.82. In terms of profitability, ZJYL's ROE is +0.04%, compared to STAA's ROE of +0.00%. Regarding short-term risk, ZJYL is more volatile compared to STAA. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check STAA's competition here
Atrion Corporation (NASDAQ: ATRI)
ZJYL vs ATRI Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas ATRI's P/E ratio is 64.50. In terms of profitability, ZJYL's ROE is +0.04%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, ZJYL is more volatile compared to ATRI. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check ATRI's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
ZJYL vs ANGO Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, ANGO has a market cap of 522.3M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while ANGO trades at $12.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas ANGO's P/E ratio is -31.85. In terms of profitability, ZJYL's ROE is +0.04%, compared to ANGO's ROE of -0.19%. Regarding short-term risk, ZJYL is more volatile compared to ANGO. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check ANGO's competition here
MiniMed Group, Inc. (NASDAQ: MMEDV)
ZJYL vs MMEDV Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, MMEDV has a market cap of 495.6M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while MMEDV trades at $17.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas MMEDV's P/E ratio is N/A. In terms of profitability, ZJYL's ROE is +0.04%, compared to MMEDV's ROE of N/A. Regarding short-term risk, ZJYL is more volatile compared to MMEDV. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check MMEDV's competition here
Embecta Corp. (NASDAQ: EMBC)
ZJYL vs EMBC Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, EMBC has a market cap of 370M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while EMBC trades at $6.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas EMBC's P/E ratio is 2.51. In terms of profitability, ZJYL's ROE is +0.04%, compared to EMBC's ROE of -0.14%. Regarding short-term risk, ZJYL is more volatile compared to EMBC. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check EMBC's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
ZJYL vs SMTI Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, SMTI has a market cap of 290.4M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while SMTI trades at $31.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas SMTI's P/E ratio is -526.83. In terms of profitability, ZJYL's ROE is +0.04%, compared to SMTI's ROE of -4.74%. Regarding short-term risk, ZJYL is more volatile compared to SMTI. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check SMTI's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
ZJYL vs OSUR Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, OSUR has a market cap of 245.5M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while OSUR trades at $3.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas OSUR's P/E ratio is -5.16. In terms of profitability, ZJYL's ROE is +0.04%, compared to OSUR's ROE of -0.15%. Regarding short-term risk, ZJYL is more volatile compared to OSUR. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check OSUR's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
ZJYL vs PDEX Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, PDEX has a market cap of 228.8M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while PDEX trades at $71.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas PDEX's P/E ratio is 19.59. In terms of profitability, ZJYL's ROE is +0.04%, compared to PDEX's ROE of +0.26%. Regarding short-term risk, ZJYL is more volatile compared to PDEX. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check PDEX's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
ZJYL vs UTMD Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, UTMD has a market cap of 208.1M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while UTMD trades at $73.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas UTMD's P/E ratio is 21.61. In terms of profitability, ZJYL's ROE is +0.04%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, ZJYL is more volatile compared to UTMD. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check UTMD's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
ZJYL vs KRMD Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, KRMD has a market cap of 178.7M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while KRMD trades at $3.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas KRMD's P/E ratio is -97.25. In terms of profitability, ZJYL's ROE is +0.04%, compared to KRMD's ROE of -0.00%. Regarding short-term risk, ZJYL is less volatile compared to KRMD. This indicates lower risk in terms of short-term price fluctuations for ZJYL.Check KRMD's competition here
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN)
ZJYL vs NNNN Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, NNNN has a market cap of 174.8M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while NNNN trades at $4.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas NNNN's P/E ratio is 26.55. In terms of profitability, ZJYL's ROE is +0.04%, compared to NNNN's ROE of +0.27%. Regarding short-term risk, ZJYL is more volatile compared to NNNN. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check NNNN's competition here
Stereotaxis, Inc. (AMEX: STXS)
ZJYL vs STXS Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, STXS has a market cap of 90.2M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while STXS trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas STXS's P/E ratio is -5.29. In terms of profitability, ZJYL's ROE is +0.04%, compared to STXS's ROE of -1.16%. Regarding short-term risk, ZJYL is more volatile compared to STXS. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check STXS's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
ZJYL vs AKYA Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas AKYA's P/E ratio is -1.34. In terms of profitability, ZJYL's ROE is +0.04%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, ZJYL is more volatile compared to AKYA. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check AKYA's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
ZJYL vs POCI Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, POCI has a market cap of 55.4M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while POCI trades at $5.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas POCI's P/E ratio is -10.98. In terms of profitability, ZJYL's ROE is +0.04%, compared to POCI's ROE of -0.24%. Regarding short-term risk, ZJYL is more volatile compared to POCI. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check POCI's competition here
SkyAI, Inc. (NASDAQ: STSS)
ZJYL vs STSS Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, STSS has a market cap of 53.7M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while STSS trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas STSS's P/E ratio is -0.02. In terms of profitability, ZJYL's ROE is +0.04%, compared to STSS's ROE of -0.99%. Regarding short-term risk, ZJYL is more volatile compared to STSS. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check STSS's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
ZJYL vs OMIC Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas OMIC's P/E ratio is -0.58. In terms of profitability, ZJYL's ROE is +0.04%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, ZJYL is more volatile compared to OMIC. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check OMIC's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
ZJYL vs IGAP Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas IGAP's P/E ratio is -10.52. In terms of profitability, ZJYL's ROE is +0.04%, compared to IGAP's ROE of +1.80%. Regarding short-term risk, ZJYL is more volatile compared to IGAP. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check IGAP's competition here
Daxor Corporation (NASDAQ: DXR)
ZJYL vs DXR Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, DXR has a market cap of 49.3M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while DXR trades at $8.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas DXR's P/E ratio is 6.86. In terms of profitability, ZJYL's ROE is +0.04%, compared to DXR's ROE of +0.13%. Regarding short-term risk, ZJYL is more volatile compared to DXR. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check DXR's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
ZJYL vs HBIO Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, HBIO has a market cap of 44.1M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while HBIO trades at $9.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas HBIO's P/E ratio is -26.89. In terms of profitability, ZJYL's ROE is +0.04%, compared to HBIO's ROE of -1.30%. Regarding short-term risk, ZJYL is more volatile compared to HBIO. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check HBIO's competition here
Nephros, Inc. (NASDAQ: NEPH)
ZJYL vs NEPH Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, NEPH has a market cap of 33.4M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while NEPH trades at $3.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas NEPH's P/E ratio is 51.17. In terms of profitability, ZJYL's ROE is +0.04%, compared to NEPH's ROE of +0.17%. Regarding short-term risk, ZJYL is more volatile compared to NEPH. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check NEPH's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
ZJYL vs SDC Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas SDC's P/E ratio is -0.03. In terms of profitability, ZJYL's ROE is +0.04%, compared to SDC's ROE of -1.96%. Regarding short-term risk, ZJYL is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for ZJYL.Check SDC's competition here
Milestone Scientific Inc. (AMEX: MLSS)
ZJYL vs MLSS Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, MLSS has a market cap of 27.9M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while MLSS trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas MLSS's P/E ratio is -6.15. In terms of profitability, ZJYL's ROE is +0.04%, compared to MLSS's ROE of -1.49%. Regarding short-term risk, ZJYL is more volatile compared to MLSS. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check MLSS's competition here
Invacare Corporation (NYSE: IVC)
ZJYL vs IVC Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas IVC's P/E ratio is -0.79. In terms of profitability, ZJYL's ROE is +0.04%, compared to IVC's ROE of -0.46%. Regarding short-term risk, ZJYL is more volatile compared to IVC. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check IVC's competition here
Retractable Technologies, Inc. (AMEX: RVP)
ZJYL vs RVP Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, RVP has a market cap of 16.6M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while RVP trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas RVP's P/E ratio is -4.62. In terms of profitability, ZJYL's ROE is +0.04%, compared to RVP's ROE of -0.05%. Regarding short-term risk, ZJYL is more volatile compared to RVP. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check RVP's competition here
Bionano Genomics, Inc. (NASDAQ: BNGO)
ZJYL vs BNGO Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, BNGO has a market cap of 13M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while BNGO trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas BNGO's P/E ratio is -0.36. In terms of profitability, ZJYL's ROE is +0.04%, compared to BNGO's ROE of -0.85%. Regarding short-term risk, ZJYL is less volatile compared to BNGO. This indicates lower risk in terms of short-term price fluctuations for ZJYL.Check BNGO's competition here
Femasys Inc. (NASDAQ: FEMY)
ZJYL vs FEMY Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, FEMY has a market cap of 12.6M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while FEMY trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas FEMY's P/E ratio is -0.33. In terms of profitability, ZJYL's ROE is +0.04%, compared to FEMY's ROE of -2.26%. Regarding short-term risk, ZJYL is more volatile compared to FEMY. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check FEMY's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
ZJYL vs RGNT Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, RGNT has a market cap of 8.9M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while RGNT trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas RGNT's P/E ratio is -0.52. In terms of profitability, ZJYL's ROE is +0.04%, compared to RGNT's ROE of N/A. Regarding short-term risk, ZJYL is more volatile compared to RGNT. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check RGNT's competition here
Lucyd, Inc (NASDAQ: LUCY)
ZJYL vs LUCY Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, LUCY has a market cap of 7.4M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while LUCY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas LUCY's P/E ratio is -0.65. In terms of profitability, ZJYL's ROE is +0.04%, compared to LUCY's ROE of -1.03%. Regarding short-term risk, ZJYL is more volatile compared to LUCY. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check LUCY's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
ZJYL vs NSTG Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas NSTG's P/E ratio is -0.03. In terms of profitability, ZJYL's ROE is +0.04%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, ZJYL is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for ZJYL.Check NSTG's competition here
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (NASDAQ: CUPR)
ZJYL vs CUPR Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, CUPR has a market cap of 4.6M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while CUPR trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas CUPR's P/E ratio is -1.24. In terms of profitability, ZJYL's ROE is +0.04%, compared to CUPR's ROE of -0.85%. Regarding short-term risk, ZJYL is more volatile compared to CUPR. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check CUPR's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
ZJYL vs POAI Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas POAI's P/E ratio is -0.38. In terms of profitability, ZJYL's ROE is +0.04%, compared to POAI's ROE of -21.19%. Regarding short-term risk, ZJYL is less volatile compared to POAI. This indicates lower risk in terms of short-term price fluctuations for ZJYL.Check POAI's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
ZJYL vs MHUA Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas MHUA's P/E ratio is 0.25. In terms of profitability, ZJYL's ROE is +0.04%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, ZJYL is more volatile compared to MHUA. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check MHUA's competition here
NEXGEL, Inc. (NASDAQ: NXGL)
ZJYL vs NXGL Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, NXGL has a market cap of 2M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while NXGL trades at $4.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas NXGL's P/E ratio is -5.84. In terms of profitability, ZJYL's ROE is +0.04%, compared to NXGL's ROE of -1.33%. Regarding short-term risk, ZJYL is less volatile compared to NXGL. This indicates lower risk in terms of short-term price fluctuations for ZJYL.Check NXGL's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVD)
ZJYL vs GMVD Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas GMVD's P/E ratio is -0.01. In terms of profitability, ZJYL's ROE is +0.04%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, ZJYL is less volatile compared to GMVD. This indicates lower risk in terms of short-term price fluctuations for ZJYL.Check GMVD's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
ZJYL vs GMVDW Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas GMVDW's P/E ratio is N/A. In terms of profitability, ZJYL's ROE is +0.04%, compared to GMVDW's ROE of +3.68%. Regarding short-term risk, ZJYL is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for ZJYL.Check GMVDW's competition here
Avinger, Inc. (NASDAQ: AVGR)
ZJYL vs AVGR Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas AVGR's P/E ratio is -0.05. In terms of profitability, ZJYL's ROE is +0.04%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, ZJYL is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for ZJYL.Check AVGR's competition here
NEXGEL, Inc. (NASDAQ: NXGLW)
ZJYL vs NXGLW Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, NXGLW has a market cap of 542.8K. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while NXGLW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas NXGLW's P/E ratio is -0.01. In terms of profitability, ZJYL's ROE is +0.04%, compared to NXGLW's ROE of -1.33%. Regarding short-term risk, ZJYL is less volatile compared to NXGLW. This indicates lower risk in terms of short-term price fluctuations for ZJYL.Check NXGLW's competition here
Lucyd, Inc (NASDAQ: LUCYW)
ZJYL vs LUCYW Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas LUCYW's P/E ratio is N/A. In terms of profitability, ZJYL's ROE is +0.04%, compared to LUCYW's ROE of -1.03%. Regarding short-term risk, ZJYL is less volatile compared to LUCYW. This indicates lower risk in terms of short-term price fluctuations for ZJYL.Check LUCYW's competition here
Hill-Rom Holdings, Inc. (NYSE: HRC)
ZJYL vs HRC Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, HRC has a market cap of 0. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas HRC's P/E ratio is 41.92. In terms of profitability, ZJYL's ROE is +0.04%, compared to HRC's ROE of +0.14%. Regarding short-term risk, ZJYL is more volatile compared to HRC. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check HRC's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
ZJYL vs ATRS Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, ATRS has a market cap of 0. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas ATRS's P/E ratio is 14.95. In terms of profitability, ZJYL's ROE is +0.04%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, ZJYL is more volatile compared to ATRS. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check ATRS's competition here
IntriCon Corporation (NASDAQ: IIN)
ZJYL vs IIN Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, IIN has a market cap of 0. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas IIN's P/E ratio is 226.45. In terms of profitability, ZJYL's ROE is +0.04%, compared to IIN's ROE of -0.00%. Regarding short-term risk, ZJYL is more volatile compared to IIN. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check IIN's competition here
Apria, Inc. (NASDAQ: APR)
ZJYL vs APR Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, APR has a market cap of 0. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas APR's P/E ratio is 22.59. In terms of profitability, ZJYL's ROE is +0.04%, compared to APR's ROE of +9.81%. Regarding short-term risk, ZJYL is more volatile compared to APR. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check APR's competition here
Invuity, Inc. (NASDAQ: IVTY)
ZJYL vs IVTY Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, IVTY has a market cap of 0. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas IVTY's P/E ratio is -3.80. In terms of profitability, ZJYL's ROE is +0.04%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, ZJYL is more volatile compared to IVTY. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check IVTY's competition here
Analogic Corporation (NASDAQ: ALOG)
ZJYL vs ALOG Comparison November 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 38.4M. In comparison, ALOG has a market cap of 0. Regarding current trading prices, ZJYL is priced at $4.91 on the NASDAQ, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 33.58, whereas ALOG's P/E ratio is 40.93. In terms of profitability, ZJYL's ROE is +0.04%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, ZJYL is more volatile compared to ALOG. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check ALOG's competition here